News by: Gavin Lumsden
Mark Mobius’s successor on Templeton Emerging Markets has overhauled the portfolio. Is it enough to revive the former stalwart?
City of London investment trust manager discusses the financial and environmental sustainability of dividends from two FTSE 100 giants.
Equity income as you've never seen it before plus special reports on private equity and who's buying commercial property trusts.
Fund manager demands Northwest Biotherapeutics appoints former FBI special agent to investigate allegations of financial impropriety.
Gavin Lumsden assesses progress in Citywire’s Top Trusts portfolio and explains why he's looking for investment trusts trading on cheap discounts.
Investors' fears about commercial property are misplaced, says Marcus Phayre-Mudge of TR Property investment trust.
Top special situations investment trust, Marwyn Value Investors, admonished for issuing new shares below their net asset value.
Shareholders in Fidelity China Special Situations investment trust to pay fund manager a performance fee despite losing 16%.
Alliance Trust has ramped up purchases of its shares, spending over £26 million this week in a determined bid to lower their discount.
Recent stock market falls encourage Sebastian Lyon, manager of the ultra defensive Personal Assets investment trust, to consider a more positive stance in future.
School and hospital projects are expensive so HICL Infrastructure Company is looking at areas like the transmission of offshore wind power.
Legal finance fund Juridica Investments is winding up its operations after a 60% slump in its share price this year.
Top-rated manager of Edinburgh investment trust reveals why he has dropped drugs giant GlaxoSmithKline from all his funds.
Could a US interest rate rise signal a turning point for battered emerging markets? Some investors believe all the bad news is priced in.
The heavily discounted Qatar Investment Fund shoots to the top of our 'expensive' table after securing its future with an unusual share offer.
A wave of blockbuster, life-saving drugs and bids will revive battered biotech stocks, says manager of Worldwide Healthcare trust.
Broker drops recommendation for private equity trust after Sherborne Investors secured seats on the board, warning of 'huge uncertainty' for the fund.
Anheuser Busch pulls off $105 billion bid for SAB Miller and Talktalk says it can handle the cost of last month's hacking attack.
Simon Champ, manager of P2P Global Investment, blames activity by rivals for recent share price weakness in direct lending funds.
Low Carbon Workplace Fund proves investor and tenant demand for environmentally friendly offices, says Columbia Threadneedle.